StockData
Rockwell Medical, Inc. logo

Rockwell Medical, Inc. (RMTI) stock

RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3080% below fair value
$6.61−0.15 (-2.22%)

Close on Nov 17, 2026Market cap $26.64MP/E –Yield –

Earnings

Rockwell Medical's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 25, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$19.10M
+20.1% on a year earlier
Adjusted EPS, Q3 FY2026
-$0.07
Latest guidance
Reaffirmed
Aug 13, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of Rockwell Medical's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Mar 25, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 12, 2026before the open$19.10M+20.1%-$0.59-$0.07Release
Q2 FY2026ended Jun 30, 2026Aug 13, 2026before the open$17.80M+10.6%-$0.34-$0.04Release
Q1 FY2026ended Mar 31, 2026May 7, 2026before the open$17.30M-8.5%-$0.04-$0.01Release
Q4 FY2025ended Dec 31, 2025Mar 26, 2026before the open$18.30M-25.9%-$0.01$0.02Release
Q3 FY2025ended Sep 30, 2025Nov 12, 2025before the open$15.90M-43.8%––Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025before the open$16.10M–-$0.05-$0.01Release
Q1 FY2025ended Mar 31, 2025May 12, 2025before the open$18.90M-16.7%-$0.04-$0.01Release
Q4 FY2024ended Dec 31, 2024Mar 20, 2025before the open$24.70M+11.8%-$0.02$0.04Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024before the open$28.30M+18.9%$0.05$0.09Release
Q1 FY2024ended Mar 31, 2024May 14, 2024before the open$22.70M+15.2%-$0.06-$0.02Release
Q4 FY2023ended Dec 31, 2023Mar 21, 2024before the open$22.10M+14.5%-$0.05$0.02Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Rockwell Medical's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Net SalesFY2026$70.00M – $75.00M$70.00M – $75.00MReaffirmedAug 13, 2026
Gross MarginFY202618% – 22%18% – 22%ReaffirmedAug 13, 2026
Adjusted EBITDAnon-GAAPFY2026$1.00M – $2.00M$1.00M – $2.00MReaffirmedAug 13, 2026
Adjusted EBITDAnon-GAAPFY2026$1.00M – $2.00M–NewMar 26, 2026

Guidance vs results

The last range Rockwell Medical gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue$65.00M – $70.00M$69.20MΣ4QWithin range
Q4 FY2023Revenue$21.30M – $22.30M$22.10MWithin range
Q3 FY2023Revenue$21.00M – $23.00M$23.80MAbove range

Guidance history

Every forecast Rockwell Medical put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Aug 13, 2026Adjusted EBITDAFY2026$1.00M – $2.00MReaffirmed
Aug 13, 2026Gross MarginFY202618% – 22%Reaffirmed
Aug 13, 2026Net SalesFY2026$70.00M – $75.00MReaffirmed
May 7, 2026Adjusted EBITDAFY2026$1.00M – $2.00MNew
May 7, 2026Gross MarginFY202618% – 22%New
May 7, 2026Net SalesFY2026$70.00M – $75.00MNew
Mar 26, 2026Adjusted EBITDAFY2026$1.00M – $2.00MNew
Nov 12, 2025Net SalesFY2025$65.00M – $70.00MNew
Aug 14, 2025Adjusted EBITDAFY2025-$500.00K – $500.00KReaffirmed
Aug 14, 2025Gross MarginFY202516% – 18%Reaffirmed
Aug 14, 2025Net SalesFY2025$65.00M – $70.00MReaffirmed
May 12, 2025Adjusted EBITDAFY2025-$500.00K – $500.00KReaffirmed
May 12, 2025Gross MarginFY202516% – 18%Reaffirmed
May 12, 2025Net SalesFY2025$65.00M – $70.00MReaffirmed
Mar 20, 2025Adjusted EBITDAFY2025-$500.00K – $500.00KNew
Mar 20, 2025Gross MarginFY202516% – 18%New
Mar 20, 2025Net SalesFY2025$65.00M – $70.00MNew
Nov 12, 2024Adjusted EBITDAFY2024$4.00M – $5.00MRaised
Nov 12, 2024Gross MarginFY202416% – 18%New
Nov 12, 2024Gross ProfitFY2024$15.00M – $17.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Rockwell Medical filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. Results
  4. News
  5. Update
  6. Results
  7. Update
  8. Results
  9. Results
  10. Update
  11. Results
  12. Results
  13. Update
  14. Results
  15. Update

See a number that looks wrong?